# Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pharmacokinetics-and-pharmacodynamics-of-rosiglitazone-in-relation-to-cyp2c8/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julia Kirchheiner,Stefanie M. Thomas,Steffen Bauer,Dorota Tomalik‐Scharte,Ursula Hering,Oxana Doroshyenko,Alexander Jetter,Simone Stehle,Martina Tsahuridu,Ingolf Meineke |
| Citations | 127 |
| DOI | 10.1016/j.clpt.2006.09.008 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2066004325 |
| PMID | 17178266 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Stefanie M. Thomas](https://scholariq.org/researchers/stefanie-m-thomas/)

## Paper primary topic

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Paper topics

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.